Nature Reviews Cardiology

(The H4-Index of Nature Reviews Cardiology is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives950
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions600
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective599
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension561
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control395
Interplay between inflammation and thrombosis in cardiovascular pathology377
Smart wearable devices in cardiovascular care: where we are and how to move forward343
Artificial intelligence-enhanced electrocardiography in cardiovascular disease management334
PPAR control of metabolism and cardiovascular functions333
Global epidemiology of dyslipidaemias324
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases295
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation292
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease287
Epidemiology of cardiovascular disease in Europe271
Pathophysiology of sepsis-induced cardiomyopathy267
Global epidemiology of valvular heart disease246
Native and bioengineered extracellular vesicles for cardiovascular therapeutics242
Transportation noise pollution and cardiovascular disease227
Self-powered cardiovascular electronic devices and systems207
Cellular and molecular pathobiology of heart failure with preserved ejection fraction205
Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6198
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis193
Epicardial adipose tissue in contemporary cardiology191
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium187
Cardiovascular disease in patients with severe mental illness176
Ceramides and other sphingolipids as drivers of cardiovascular disease169
Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes168
The role of cardiac rehabilitation in improving cardiovascular outcomes167
Heart failure with mid-range or mildly reduced ejection fraction165
Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms165
Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging152
Systems biology in cardiovascular disease: a multiomics approach145
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?139
Lifestyle interventions for the prevention and treatment of hypertension138
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches135
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity134
Optical coherence tomography in coronary atherosclerosis assessment and intervention133
Epidemiology of the inherited cardiomyopathies130
Sit less and move more for cardiovascular health: emerging insights and opportunities129
The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy120
Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management120
Pregnancy and cardiovascular disease115
Genomics of hypertension: the road to precision medicine108
Transforming growth factor-β in myocardial disease103
High-density lipoproteins, reverse cholesterol transport and atherogenesis102
Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target100
Cardiac optogenetics: a decade of enlightenment99
Apolipoproteins in vascular biology and atherosclerotic disease99
The role of cellular senescence in cardiac disease: basic biology and clinical relevance98
Genomic frontiers in congenital heart disease98
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development96
Blood pressure and its variability: classic and novel measurement techniques94
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease93
Mechanisms and consequences of endothelial cell senescence91
Catheter ablation for atrial fibrillation: current indications and evolving technologies90
Vascular endothelial cell development and diversity86
Complete versus incomplete coronary revascularization: definitions, assessment and outcomes83
Cardiovascular risks of climate change82
Applications of artificial intelligence in cardiovascular imaging82
Climate change and cardiovascular disease: implications for global health81
The role of mitochondrial fission in cardiovascular health and disease77
Cardiac involvement in the long-term implications of COVID-1977
RNA-targeting and gene editing therapies for transthyretin amyloidosis75
Epidemiology and prevention of venous thromboembolism74
Update on the pathophysiology and medical treatment of peripheral artery disease74
Sulfide regulation of cardiovascular function in health and disease74
Bleeding avoidance strategies in percutaneous coronary intervention73
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action72
Obesity and the risk of cardiometabolic diseases72
Branched-chain amino acids in cardiovascular disease71
Myocardial stunning and hibernation revisited71